James M. Larner

5.6k total citations
151 papers, 4.3k citations indexed

About

James M. Larner is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Molecular Biology. According to data from OpenAlex, James M. Larner has authored 151 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pulmonary and Respiratory Medicine, 45 papers in Radiation and 42 papers in Molecular Biology. Recurrent topics in James M. Larner's work include Advanced Radiotherapy Techniques (44 papers), Glioma Diagnosis and Treatment (20 papers) and Brain Metastases and Treatment (19 papers). James M. Larner is often cited by papers focused on Advanced Radiotherapy Techniques (44 papers), Glioma Diagnosis and Treatment (20 papers) and Brain Metastases and Treatment (19 papers). James M. Larner collaborates with scholars based in United States, United Kingdom and Taiwan. James M. Larner's co-authors include David L. Brautigan, Ke Sheng, David R. Jones, Paul W. Read, Stanley Benedict, Jason P. Sheehan, Benjamin D. Kozower, Joyce L. Hamlin, Jing Cai and Frank C. Detterbeck and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

James M. Larner

148 papers receiving 4.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
James M. Larner 1.8k 1.1k 943 851 843 151 4.3k
E. Brian Butler 2.1k 1.2× 792 0.7× 1.2k 1.3× 842 1.0× 917 1.1× 227 4.7k
Daniel A. Hamstra 2.0k 1.1× 1.1k 1.0× 710 0.8× 1.7k 2.0× 806 1.0× 159 5.0k
Kazuhiko Ogawa 2.0k 1.1× 1.2k 1.1× 1.3k 1.4× 900 1.1× 1.1k 1.3× 320 5.7k
Steve Braunstein 1.2k 0.6× 1.2k 1.1× 1.0k 1.1× 779 0.9× 488 0.6× 205 4.2k
Arnold M. Markoe 1.6k 0.9× 515 0.5× 1.1k 1.2× 1.1k 1.3× 889 1.1× 203 4.9k
Ute Ganswindt 2.2k 1.3× 653 0.6× 635 0.7× 1.5k 1.7× 1.3k 1.5× 166 4.4k
Susan Short 1.2k 0.7× 1.4k 1.2× 708 0.8× 1.5k 1.8× 622 0.7× 159 4.2k
Daniel M. Aebersold 1.4k 0.8× 1.4k 1.2× 1.2k 1.3× 625 0.7× 609 0.7× 225 4.6k
Mitsuyuki Abe 1.6k 0.9× 456 0.4× 749 0.8× 837 1.0× 675 0.8× 155 3.8k
Steven J. Chmura 2.5k 1.4× 1.0k 0.9× 2.5k 2.6× 1.2k 1.4× 1.0k 1.2× 172 6.0k

Countries citing papers authored by James M. Larner

Since Specialization
Citations

This map shows the geographic impact of James M. Larner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Larner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Larner more than expected).

Fields of papers citing papers by James M. Larner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Larner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Larner. The network helps show where James M. Larner may publish in the future.

Co-authorship network of co-authors of James M. Larner

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Larner. A scholar is included among the top collaborators of James M. Larner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Larner. James M. Larner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aliotta, Eric, et al.. (2024). Predicting radiation‐induced immune suppression in lung cancer patients treated with stereotactic body radiation therapy. Medical Physics. 51(9). 6485–6500. 4 indexed citations
2.
Clark, Evan, et al.. (2023). ZEB1 promotes non-homologous end joining double-strand break repair. Nucleic Acids Research. 51(18). 9863–9879. 7 indexed citations
5.
Zakharov, Alexey, Sukumar Sarkar, Shyh‐Ming Yang, et al.. (2021). A Genome-Edited ERα-HiBiT Fusion Reporter Cell Line for the Identification of ERα Modulators Via High-Throughput Screening and CETSA. Assay and Drug Development Technologies. 19(8). 539–549. 4 indexed citations
6.
Thor, Maria, Joseph O. Deasy, Chen Hu, et al.. (2020). Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617. Clinical Cancer Research. 26(17). 4643–4650. 45 indexed citations
7.
Kowalchuk, Roman O., et al.. (2020). A single-institutional experience with low dose stereotactic body radiation therapy for liver metastases. Reports of Practical Oncology & Radiotherapy. 25(6). 987–993. 1 indexed citations
8.
Sarkar, Sukumar, et al.. (2019). Aurora B Kinase Promotes CHIP-Dependent Degradation of HIF1α in Prostate Cancer Cells. Molecular Cancer Therapeutics. 19(4). 1008–1017. 10 indexed citations
9.
Dziegielewski, Jaroslaw, Ewa Poniecka, Jinho Heo, et al.. (2019). Deletion of the SAPS1 subunit of protein phosphatase 6 in mice increases radiosensitivity and impairs the cellular DNA damage response. DNA repair. 85. 102737–102737. 5 indexed citations
10.
Sarkar, Sukumar, et al.. (2017). The E3 Ligase CHIP Mediates p21 Degradation to Maintain Radioresistance. Molecular Cancer Research. 15(6). 651–659. 35 indexed citations
11.
Sarkar, Sukumar, David L. Brautigan, & James M. Larner. (2017). Aurora Kinase A Promotes AR Degradation via the E3 Ligase CHIP. Molecular Cancer Research. 15(8). 1063–1072. 28 indexed citations
12.
Stinchcombe, Thomas E., David Kozono, Joseph K. Salama, et al.. (2017). MA 17.07 Veliparib in Combination with Paclitaxel/Carboplatin (P/C)-Based Chemoradiotherapy (CRT) in Patients with Stage III NSCLC. Journal of Thoracic Oncology. 12(11). S1874–S1874. 1 indexed citations
13.
Chen, Long, Jie Li, Elia Farah, et al.. (2016). Cotargeting HSP90 and Its Client Proteins for Treatment of Prostate Cancer. Molecular Cancer Therapeutics. 15(9). 2107–2118. 29 indexed citations
14.
Trifiletti, Daniel M., James M. Larner, & Jason P. Sheehan. (2016). When should patients with brain metastases receive whole brain irradiation?. Europe PMC (PubMed Central). 4(1). 1–3. 4 indexed citations
15.
Ta, Huy Q., Melissa L. Ivey, Henry F. Frierson, et al.. (2015). Checkpoint Kinase 2 Negatively Regulates Androgen Sensitivity and Prostate Cancer Cell Growth. Cancer Research. 75(23). 5093–5105. 18 indexed citations
16.
Dziegielewska, Barbara, David L. Brautigan, James M. Larner, & Jaroslaw Dziegielewski. (2013). T-Type Ca2+ Channel Inhibition Induces p53-Dependent Cell Growth Arrest and Apoptosis through Activation of p38-MAPK in Colon Cancer Cells. Molecular Cancer Research. 12(3). 348–358. 52 indexed citations
17.
Cai, Jing, Paul W. Read, James M. Larner, et al.. (2010). Effects of breathing variation on gating window internal target volume in respiratory gated radiation therapya). Medical Physics. 37(8). 3927–3934. 34 indexed citations
18.
Sheng, Ke, et al.. (2008). Is daily computed tomography image guidance necessary for nasal cavity and nasopharyngeal radiotherapy? An investigation based on helical tomotherapy. Journal of Applied Clinical Medical Physics. 9(1). 36–46. 22 indexed citations
19.
Larner, James M., Hoyun Lee, & Joyce L. Hamlin. (1994). Radiation Effects on DNA Synthesis in a Defined Chromosomal Replicon. Molecular and Cellular Biology. 14(3). 1901–1908. 19 indexed citations
20.
Larner, James M., et al.. (1991). Tolosa-Hunt syndrome A radiation responsive syndrome. Neuro-Ophthalmology. 11(5). 289–292. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026